Format

Send to

Choose Destination
Haematologica. 2019 Apr;104(4):e143-e146. doi: 10.3324/haematol.2018.204792. Epub 2018 Nov 8.

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.

Author information

1
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington.
2
Department of Medicine, Division of Hematology, University of Washington.
3
Public Health Sciences Division, Fred Hutchinson Cancer Research Center.
4
Department of Medicine, Division of Medical Oncology, University of Washington.
5
Seattle Cancer Care Alliance.
6
Deparment of Pharmacy Services, University of Washington.
7
Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center.
8
Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington rwalter@fredhutch.org.
9
Department of Epidemiology, University of Washington, Seattle, WA, USA.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center